CXCR4 promotes GSK3β expression in pancreatic cancer cells via the Akt pathway

被引：0
作者：
Shijie Ma
Qianjun Li
Feng Pan
机构：
[1] Nanjing Medical University,Department of Gastroenterology, Huai’an First People’s Hospital
来源：
International Journal of Clinical Oncology | 2015年 / 20卷
关键词：
CXCR4 receptor; Glycogen synthase kinase 3; Pancreatic cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：525 / 530
页数：5
相关论文
共 9 条
[1]  
Wörmann SM(2013) Risk factors and therapeutic targets in pancreatic cancer Front Oncol 3 1-17
[2]  
Algül H(2007)Beta-catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer Med Hypotheses 69 816-820
[3]  
Wang Z(2010)GSK3: a multifaceted kinase in Wnt signaling Trends Biochem Sci 35 161-168
[4]  
Ma Q(2009)Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy BMC Cancer 9 132-undefined
[5]  
Wu D(undefined)undefined undefined undefined undefined-undefined
[6]  
Pan W(undefined)undefined undefined undefined undefined-undefined
[7]  
Mamaghani S(undefined)undefined undefined undefined undefined-undefined
[8]  
Patel S(undefined)undefined undefined undefined undefined-undefined
[9]  
Hedley DW(undefined)undefined undefined undefined undefined-undefined
1